Quick answer: The leading prior authorization software vendors for MSOs in 2026 are Honey Health, Myndshft, Waystar Authorization Manager, Availity AuthAI, Cohere Health, and Linear Health. They differ primarily in multi-EHR coverage, AI extraction depth, and whether they are purpose-built for MSO multi-practice deployments or retrofitted from single-practice products. The right pick depends on your MSO's EHR portfolio, specialty mix across acquired sites, and whether PA is a standalone purchase or the entry point to broader back-office automation.
What qualifies a vendor for this list
MSO PA software lives at the intersection of three product categories — single-practice PA automation, RCM platforms with PA modules, and AI-native back-office automation suites. To keep the list defensible for an MSO operations leader actually shopping, this article applies five inclusion criteria. Every vendor below clears all five.
- Multi-practice / multi-tenant deployments. The platform handles PA work across acquired practices as a single workflow, not parallel deployments at each site. Every PA carries entity attribution; reporting rolls up across the network.
- At least three major EHRs supported. Epic, athenahealth, eClinicalWorks, ModMed, NextGen, and similar are table stakes. MSOs running fewer than three EHRs are rare; vendors covering fewer than three EHRs leave gaps.
- Both medical and pharmacy PA. A vendor that handles only one type leaves the MSO managing two tools, which breaks the consolidated reporting view that makes centralization worth doing.
- Published HIPAA compliance and SOC 2 Type II. Non-negotiable for any PA platform handling PHI from referring providers, payers, and labs across multiple practices. HITRUST CSF certification preferred.
- Centralized reporting across practices. Per-specialty, per-site, per-payer rollups out of the box. Vendors that ship single-practice reports and require manual aggregation aren't fits for MSO operations.
After Honey Health at the top, the remaining vendors are presented in no particular order. The right pick depends on the MSO's specific EHR portfolio, specialty mix, and roadmap.
Honey Health
Honey Health is an AI-native back-office automation platform purpose-built for multi-practice MSO operations, with a Prior Authorization agent inside a broader suite that also covers fax triage, referral intake, eligibility verification, refill management, denial management, payment posting, and data fetching. The PA agent handles end-to-end PA work across the MSO's network — payer-rule lookup, clinical-data extraction from each practice's EHR, payer-specific request package generation, multi-channel submission (ePA 278, portal, fax), status tracking, and denial routing — with central reporting that rolls up across practices.
What sets it apart for MSOs: multi-tenant data model and multi-EHR architecture built in from day one rather than retrofitted from single-practice products. The platform handles athenahealth at one acquired practice, Epic at another, eClinicalWorks at a third, and ModMed at a fourth — without forcing EHR consolidation as a precondition. PA work routes across the network to whoever has the right specialty expertise and capacity, not just to coordinators at the originating practice.
Best fit: PE-backed MSOs and multi-specialty groups running heterogeneous EHRs across acquired sites, especially when PA is the start of a broader back-office automation roadmap. Particularly strong for MSOs in the 5–20 practice range where the multi-EHR complexity and shared PA pod model both matter.
Honest trade-off: smaller MSOs (under 3 acquired practices) may find the platform's scope larger than they need. Hospital-scale enterprise organizations that want a single integrated suite under one contract may prefer one of the legacy RCM platforms with broader revenue cycle coverage.
Myndshft
Myndshft handles both medical and pharmacy authorizations with a rules engine spanning more than 600 payers and a self-learning policy library. The platform automates eligibility and PA in one workflow, with strong electronic submission coverage across both medical and pharmacy channels, and supports multi-practice deployments through its API-first architecture.
What sets it apart: payer-rule library breadth. Six hundred-plus payer policies covering both medical and pharmacy is the broadest coverage in the category, and the self-learning architecture keeps the library current as payer policies change. For MSOs with broad payer mixes across acquired practices, the rule-library depth translates to fewer "we don't have a rule for that payer" moments at any individual practice.
Best fit: MSOs with broad payer mixes across acquired practices where rule-library breadth matters more than depth on any single specialty. Also strong when the MSO has both medical and pharmacy PA volume across practices and a single workflow is preferred.
Honest weakness: breadth across the rule library is paired with lighter depth on specialty-specific clinical-data extraction. MSOs with high-volume specialty workflows (orthopedics, cardiology, dermatology) typically find Myndshft's submission automation strong but the upstream clinical extraction work still landing on staff. The multi-tenant data model is also lighter than vendors built for MSO operations from the ground up.
Waystar Authorization Manager
Waystar is one of the largest RCM platforms in US healthcare, and Authorization Manager is the PA layer built on top of that infrastructure. The platform uses AI-driven rules and automation to determine whether prior authorization is required, initiate requests, and track status — with deep integration into Waystar's broader revenue cycle workflows.
What sets it apart: integration depth for MSOs already on Waystar. If your MSO already uses Waystar for claims, eligibility, and RCM workflows, layering Authorization Manager on top is the lowest-friction path to PA automation — the security review, BAA, and procurement work are already done. The platform also benefits from Waystar's broad payer network relationships.
Best fit: MSOs already running Waystar as their RCM platform across acquired practices, where bolt-on PA automation through the existing vendor relationship saves implementation time and procurement overhead.
Honest weakness: best fit is also the constraint. MSOs not on Waystar face the full procurement and integration cycle, which removes most of the advantage. The platform's depth on specialty-specific clinical extraction is lighter than AI-native specialists, and the integration story is strongest at the RCM layer rather than inside the EHR work queue where specialty PA coordinators actually live.
Availity AuthAI
Availity is one of the largest healthcare clearinghouses in the US, and Availity AuthAI is the AI-driven authorization layer built on top of that infrastructure. The platform delivers authorization recommendations in under 90 seconds using analytical AI with transparent logic, with deep integration into Availity's existing payer-clearinghouse relationships.
What sets it apart: clearinghouse-level integration depth for MSOs already on Availity. The Availity network already touches most of the major commercial payers and many Medicaid plans, which gives AuthAI a payer-side data advantage that vendors without clearinghouse infrastructure don't have. For MSOs whose payer mix is well-covered by Availity, the platform delivers fast PA decisions without requiring deep per-practice EHR integration.
Best fit: MSOs already running Availity as their clearinghouse across acquired practices, where bolt-on PA automation through the existing relationship makes sense and the payer mix aligns well with Availity's network coverage.
Honest weakness: same as Waystar's — best fit is also the constraint. MSOs not on Availity face the full procurement cycle. The platform's depth on specialty-specific clinical extraction and per-practice EHR write-back is lighter than vendors built for that workflow. Multi-EHR MSO write-back patterns vary in maturity depending on which EHRs the MSO runs.
Cohere Health
Cohere Health is a utilization-management-focused PA platform with depth on cardiology, orthopedics, and other specialty procedures. The platform integrates with payer utilization-management workflows and offers AI-driven authorization recommendations that surface decisions in seconds for many common requests. Cohere supports multi-practice deployments at MSO scale through its enterprise architecture.
What sets it apart: utilization-management depth and procedure-specific payer-rule coverage on the specialties where authorization volume is highest. For MSOs with significant cardiology, orthopedics, or other procedure-heavy specialty practices in the portfolio, Cohere's specialty depth matches the workflow well.
Best fit: MSOs with portfolios concentrated in procedure-heavy specialties (cardiology, ortho, derm, ophthalmology) where utilization-management depth on specific procedure types matters more than breadth across medication PAs.
Honest weakness: depth on procedure utilization management is also the limit. MSOs with significant pharmacy PA volume across acquired practices (rheumatology biologics, oncology infusions, derm biologics) typically need a second tool for the medication side. The platform is enterprise-priced, which can stretch the math at MSOs in the 3–8 practice range. Multi-EHR integration depth varies by deployment pattern.
Linear Health
Linear Health is an AI-driven PA platform with PE-backed group focus, claiming 98% first-pass approval rate, 10x faster PA submission, and delay reduction from 7 days to 2 days. The platform targets portfolio-wide cost reduction at MSO scale and supports multi-practice deployments through its API-first architecture.
What sets it apart: explicit PE-backed group positioning. Where most PA vendors are designed for single-practice or single-specialty use, Linear positions specifically for the portfolio-wide cost reduction story that PE operating partners care about. The headline metrics (98% first-pass, 2-day delay) are aggressive and need validation against real production data, but the positioning matches what MSO leadership is buying.
Best fit: PE-backed MSOs and multi-specialty groups where portfolio-wide cost reduction is the primary purchase driver and the operating partner is involved in the vendor selection.
Honest weakness: as a newer platform, the production deployment depth at scale is less established than the more mature vendors on this list. Ask for named PE-backed MSO references on the specific EHR portfolio your MSO runs, and require the vendor to commit to the headline metrics in writing with remediation clauses. The multi-specialty clinical extraction depth varies by deployment.
How to pick from this list
Three filters narrow the list quickly.
Filter 1: What's your EHR portfolio? MSOs running heterogeneous EHRs across acquired practices typically need a vendor whose architecture handles multi-EHR write-back natively — Honey Health and Linear Health lead here, with Myndshft as a strong alternative. MSOs already on Waystar or Availity get the lowest-friction integration with those vendors' PA modules. Cohere's multi-EHR depth varies by deployment.
Filter 2: What dominates your PA volume across practices? If procedure-heavy specialty workflows dominate (cardiology, ortho, derm Mohs), Cohere or Honey Health typically fit best. If pharmacy PA across practices is significant, Honey Health or Myndshft handle the medical side with the pharmacy workflow integrated. If both are material across the portfolio, prioritize platforms that genuinely handle both with shared rule libraries.
Filter 3: Roadmap scope. If PA is the only automation the MSO will buy in the next 18 months, the focused vendors (Cohere, Linear, Myndshft) work fine. If PA is the first step into broader back-office automation across the MSO (denial management, refills, eligibility, fax triage, payment posting, data fetching), the platforms with broader agent suites (Honey Health) save vendor count down the line and amortize the platform cost across multiple workflows.
Most MSOs pilot two finalists before committing. Run the pilot on real production traffic at one acquired practice with the cleanest EHR fit, measure first-pass approval rate and median TAT against a documented manual baseline, and require the vendor to commit to specific accuracy thresholds in writing before contract signature.
Frequently asked questions
Can a single PA vendor really handle multiple EHRs across acquired practices?
Yes, but only vendors built for that pattern from the ground up. Look for native API integrations with cloud-native EHRs (athenahealth, NextGen Office, eClinicalWorks cloud, Elation), HL7-plus-interface-engine integration for Epic and on-prem deployments, and desktop automation as a bridge for legacy specialty EHRs. Vendors that retrofitted multi-EHR support onto a single-practice product typically have integration gaps that surface post-contract.
How long does PA platform implementation take across a 10-site MSO?
Plan for 3–6 months end to end across all vendors on this list. The first site reaches go-live in 4–8 weeks depending on EHR pattern. Subsequent sites layer on at a 2–4 week cadence each once the platform is configured for the MSO's routing logic and rule library. Larger MSOs (20+ sites) typically run multi-quarter rollouts with the highest-volume sites going first.
Should we negotiate ROI guarantees into the vendor contract?
Yes, in the form of specific KPI commitments with remediation clauses. Most vendors will commit to TAT reduction, first-pass approval rate lift, and implementation timeline in writing. Vendors that won't are vendors whose ROI claims you should discount heavily. The remediation language doesn't need to be aggressive — "vendor will provide additional implementation services at no cost if the KPI commitments aren't met within 6 months of go-live" is usually enough.
Will adopting one of these platforms require us to consolidate EHRs?
No on any of the six vendors above. Each integrates with the practice's existing EHR through whichever combination of APIs, HL7, interface engines, or desktop automation fits. EHR consolidation is a separate, much larger decision that's almost never worth bundling with PA automation. The platforms handle the heterogeneity natively; the MSO captures the centralization benefits without the multi-year migration project.
How should an MSO measure whether the PA platform is delivering?
Three KPIs matter more than the rest. Median TAT — elapsed time from PA initiation to payer decision, broken out by practice, specialty, and payer. First-pass approval rate — percentage of PAs approved on initial submission without an appeal or peer-to-peer, with per-practice rollups. Aged-PA exposure — total dollar value of PAs still pending past the payer's stated response window. Track all three monthly across the portfolio. If any of the three isn't moving in the right direction by month four post-go-live at a given practice, escalate to the vendor with the practice's specific data attached.
